Millions of men pop a saw palmetto capsule every night believing it shrinks their prostate, but the best science says it does nothing more than a sugar pill.
Quick Take
- The largest, most rigorous trial on saw palmetto found no real benefit over a placebo for urinary symptoms.
- Early small studies hinted at modest relief, which is why the supplement became so popular in the first place.
- Major reviews pooling thousands of men found no improvement in urine flow or prostate size, even at triple doses.
- Commercial saw palmetto products vary wildly, so even honest marketing claims may not match what’s actually in the bottle.
A Supplement Built On Hope, Not Proof
Saw palmetto has sat on pharmacy shelves for decades as a go-to fix for men dealing with frequent bathroom trips and weak urine flow caused by an enlarged prostate. The appeal makes sense. It’s cheap, it’s natural, and early research gave men a reason to believe. But newer, better-designed studies tell a very different story than the one still printed on supplement labels today.
A National Institutes of Health-funded trial called CAMUS put the supplement to a real test. Researchers followed 369 men for 72 weeks, comparing saw palmetto against a placebo. Urinary symptom scores dropped in both groups, but the group taking the placebo actually did slightly better, by 0.79 points on a standard symptom scale. The difference was not even close to statistically meaningful.
What The Bigger Reviews Found
CAMUS wasn’t a one-off result. A Cochrane review covering 32 randomized trials and 5,666 men found no improvement in urinary flow or prostate size, even when researchers doubled or tripled the usual dose. A more recent review of 27 studies, summarized by the American Academy of Family Physicians, reached the same conclusion: no meaningful improvement in symptoms or quality of life, whether men took it for a few months or over a year.
The National Institutes of Health’s own research arm has been blunt about it, too. The agency’s description of the CAMUS study states plainly that saw palmetto extract, even at three times the standard dose, had no greater effect than placebo on urinary symptoms or any other outcome tied to an enlarged prostate. That’s about as close to a closed case as clinical research gets.
Why So Many Men Still Swear By It
So why does the belief persist? Earlier, smaller studies did report modest symptom relief, and that early data built the supplement’s reputation long before the bigger trials came along. Some outlets have even suggested saw palmetto performs similarly to prescription drugs like tamsulosin for easing symptoms, though the trial behind that specific claim isn’t clearly identified or detailed. That’s the kind of claim a skeptical reader should want backed by real numbers before buying in.
There’s also a practical wrinkle nobody advertises on the label. The CAMUS trial tested one specific extract, and researchers still don’t fully know its active ingredients or how it’s supposed to work in the body. Commercial saw palmetto comes in berry powders, blended formulas, and extracts with no shared standard, meaning the product sitting in your medicine cabinet may bear little resemblance to anything actually studied [this is consistent with broader supplement-variability findings].
The Bottom Line For Men Weighing Their Options
None of this means saw palmetto is dangerous. It’s generally well tolerated with few side effects. But “safe” and “effective” are two different words, and the evidence gap between them matters when a man delays seeing a urologist because he’s trusting a bottle instead of a diagnosis. An enlarged prostate can mimic infections, medication side effects, or more serious conditions worth ruling out early.
Common sense says follow where the strongest data leads, not where early buzz or clever marketing points. For now, the honest answer from the biggest and best-run studies is that saw palmetto looks no better than a placebo for prostate symptoms. Men over 40 deserve that straight talk before they spend another dollar, or another year, betting their health on it.
Sources:
menshealth.com, pmc.ncbi.nlm.nih.gov, nih.gov, nccih.nih.gov, aafp.org
